Health and economic burden of sugar-sweetened beverages consumption in Brazil.


Journal

Cadernos de saude publica
ISSN: 1678-4464
Titre abrégé: Cad Saude Publica
Pays: Brazil
ID NLM: 8901573

Informations de publication

Date de publication:
2023
Historique:
received: 30 12 2022
accepted: 31 08 2023
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: epublish

Résumé

Sugar-sweetened beverages (SSBs) are a major source of added sugar and are associated with noncommunicable diseases (NCDs) such as obesity and diabetes. This study assessed the impact of SSBs consumption on disease burden in Brazil, including deaths, disability-adjusted life years (DALYs), and healthcare costs. A 3-stage methodology was used to assess the direct effects of SSBs on diabetes, cardiovascular diseases, and body mass index (BMI), along with the influence of BMI on disease incidence. These assessments were then used to estimate the economic and health burden using population-attributable factors. Results showed that 2.7% and 11% of adult and children overweight/obesity cases were attributable to SSBs, respectively. SSBs consumption in Brazil led to 1,814,486 cases, 12,942 deaths, 362,088 DALYs, and USD 2,915.91 million in medical costs related to diabetes, cardiovascular diseases, oncological diseases, and other NCDs. Urgent implementation of public policies is crucial to address the consumption of SSBs, recognized as a key risk factor for NCDs.

Identifiants

pubmed: 38126558
pii: S0102-311X2023001205008
doi: 10.1590/0102-311XEN249422
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00249422

Auteurs

Lucas Perelli (L)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Andrea Alcaraz (A)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Cid Manso de Mello Vianna (CMM)

Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil.

Natalia Espinola (N)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Federico Rodriguez Cairoli (FR)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Ariel Bardach (A)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

Alfredo Palacios (A)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.
Centre for Health Economics, University of York, York, U.K.

Dario Balan (D)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Paula Johns (P)

ACT Promoção da Saúde, Rio de Janeiro, Brasil.

Federico Augustovski (F)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Andrés Pichón-Rivière (A)

Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Classifications MeSH